Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for this essential antibacterial agent, ensuring timely delivery and regulatory compliance.

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections.

- Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective for skin, soft‑tissue and pneumonia caused by MRSA. - Vancomycin‑resistant Enterococcus (VRE) infections: provides an option when vancomycin is ineffective. - Community‑acquired pneumonia (CAP) caused by susceptible Gram‑positive organisms: improves clinical outcomes. - Skin and soft‑tissue infections (SSTI) caused by susceptible Gram‑positive bacteria: reduces bacterial load and promotes healing.

Linezolid may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient headache. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Thrombocytopenia: reduced platelet count. - Peripheral neuropathy: nerve damage with prolonged use. - Serotonin syndrome: risk when combined with serotonergic agents. - Optic neuritis: inflammation of the optic nerve.

Before prescribing Linezolid, consider the following precautions.

- Renal impairment: dose adjustment may be required. - Hepatic dysfunction: monitor liver enzymes. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Long‑term therapy (>14 days): monitor blood counts for myelosuppression. - Pregnancy and lactation: use only if benefit outweighs risk. - Store at room temperature: keep in original container, protect from moisture and light.

Linezolid can interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increased serotonergic toxicity. - Rifampicin: reduces linezolid plasma concentrations. - Erythromycin: may increase linezolid levels.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR. - Anticonvulsants (e.g., carbamazepine): may affect metabolism. - NSAIDs: monitor for bleeding risk.